替格瑞洛联合急诊PCI治疗糖尿病患者急性ST段抬高型心肌梗死临床效果评价(1)
[摘要] 目的 探究替格瑞洛联合急诊PCI对糖尿病患者急性ST段抬高型心肌梗死的临床治疗效果。方法 选取2018年6月—2019年6月该院急诊科收治的糖尿病合并急性ST段抬高型心肌梗死患者共60例,按照入院的先后顺序随机分为替格瑞洛组和氯吡格雷组,替格瑞洛组采取替格瑞勒配合急诊PCI治疗,氯吡格雷组采用氯吡格雷配合急诊PCI治疗,对比替格瑞洛组和氯吡格雷组患者的术后恢复情况、血糖改善状况以及临床治疗效果。结果 经治疗后替格瑞洛组患者血糖指标显著低于氯吡格雷组,且术后患者并发症率低于氯吡格雷组(P<0.05),具有可比性。结论 替格瑞洛联合急诊PCI治疗糖尿病患者急性ST段抬高型心肌梗死的效果非常好。[关键词] 替格瑞洛;急诊PCI;糖尿病;急性ST段抬高型心肌梗死;临床治疗效果
[Abstract] Objective To investigate the clinical effect of tigrelor combined with emergency PCI on acute ST-elevation myocardial infarction in patients with diabetes. Methods A total of 60 patients with diabetes and acute ST-elevation myocardial infarction treated in the emergency department from June 2018 to June 2019 were randomly divided into ticagrelor and clopidogrel groups according to the order of admission. The ticagrelor group was treated with tigerelide and emergency PCI ......
您现在查看是摘要页,全文长 3622 字符。